Jeffrey Bonnaud, PA
Medical · Los Angeles, CANPI 1275939332
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $225,603 of the $313,844 with a category attached, or 71.9%. 30 manufacturers reported payments, led by Lilly USA, LLC at 36.8% of the total. 2025 is the largest year on record at $111,891, more than ten times the $5,735 reported in 2021. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,265 payments — averaging $248.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$116K
- Johnson & Johnson$50K
- UCB, Inc.$42K
- Arcutis Biotherapeutics, Inc.$29K
- Dermavant Sciences, Inc.$20K
- AbbVie$19K
- plus $39K from 24 others
What the payments were for
- Consulting fees$30,37610%
- Speaking & faculty fees$225,60372%
- Travel & lodging$24,8718%
- Food & beverage$32,36510%
- Education$6290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 254 | $115,507 |
| Johnson & Johnson | 120 | $49,765 |
| UCB, Inc. | 137 | $41,668 |
| Arcutis Biotherapeutics, Inc. | 74 | $28,864 |
| Dermavant Sciences, Inc. | 76 | $20,216 |
| AbbVie(2 entities) | 125 | $18,638 |
| Janssen Scientific Affairs, LLC | 33 | $16,556 |
| Organon | 19 | $7,694 |
| Novartis | 42 | $2,414 |
| Galderma Laboratories, L.p. | 62 | $1,572 |
| Sun Pharmaceutical Industries Inc. | 56 | $1,560 |
| LEO Pharma Inc. | 30 | $1,528 |
| Incyte Corporation | 51 | $1,486 |
| Boehringer Ingelheim | 6 | $1,477 |
| Sanofi | 27 | $1,290 |
| E.r. Squibb & Sons, L.L.C. | 33 | $847 |
| Regeneron Healthcare Solutions, Inc. | 22 | $719 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $591 |
| Mayne Pharma Commercial LLC | 34 | $459 |
| Pfizer | 20 | $308 |
| Amgen | 6 | $157 |
| Journey Medical Corporation | 7 | $139 |
| Almirall LLC | 6 | $127 |
| Sanofi-aventis U.S. LLC | 2 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Revance Therapeutics, Inc. | 1 | $32 |
| Strata Skin Sciences, Inc. | 1 | $20 |
| EPI Health, LLC | 1 | $18 |
| Eli Lilly | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$313,844 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 18 | $226 |
| Triamcinolone Acetonide | 11 | $132 |
Paid to pharmacies, not to this prescriber.
Other medical in Los Angeles
- Kenny Davis TrinidadLos Angeles$99K
- Cheiny ShiauLos Angeles$86K
- Xochitl RentelnLos Angeles$38K
- Charlotte CarlsonLos Angeles$30K
- Dorna YaghoobzadehLos Angeles$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.